{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T13:11:03Z","timestamp":1782738663222,"version":"3.54.5"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T00:00:00Z","timestamp":1712534400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020668","name":"European Research Executive Agency","doi-asserted-by":"publisher","award":["101079210"],"award-info":[{"award-number":["101079210"]}],"id":[{"id":"10.13039\/100020668","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008363","name":"Kr\u00e6ftens Bek\u00e6mpelse","doi-asserted-by":"publisher","award":["2021 R322-A17350"],"award-info":[{"award-number":["2021 R322-A17350"]}],"id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007460","name":"Arvid Nilssons Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007460","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010359","name":"L\u00e6geforeningens Forskningsfond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007403","name":"Dagmar Marshalls Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007403","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","giejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastrointestinal Endoscopy"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.gie.2024.04.012","type":"journal-article","created":{"date-parts":[[2024,4,7]],"date-time":"2024-04-07T18:21:34Z","timestamp":1712514094000},"page":"750-755","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["EUS-guided biopsies versus surgical specimens for establishing patient-derived pancreatic cancer organoids: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3524-1133","authenticated-orcid":false,"given":"Simon Ezban","family":"Gr\u00fctzmeier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafsa Mahad Mahamud","family":"Sodal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bojan","family":"Kovacevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Vilmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G\u00e1sdal","family":"Karstensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Klausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gie.2024.04.012_bib1","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.4708","article-title":"Estimated projection of US cancer incidence and death to 2040","volume":"4","author":"Rahib","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.gie.2024.04.012_bib2","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1158\/1078-0432.CCR-20-4116","article-title":"Organoid sensitivity correlates with therapeutic response in patients with pancreatic cancer","volume":"28","author":"Grossman","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.gie.2024.04.012_bib3","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.158060","article-title":"Culture media composition influences patient-derived organoid ability to predict therapeutic responses in gastrointestinal cancers","volume":"7","author":"Hogenson","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.gie.2024.04.012_bib4","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1038\/s41467-022-29857-6","article-title":"Integrated profiling of human pancreatic cancer organoids reveals chromatin accessibility features associated with drug sensitivity","volume":"13","author":"Shi","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.gie.2024.04.012_bib5","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1038\/s41401-022-00897-4","article-title":"Pan-KRAS inhibitors suppress proliferation through feedback regulation in pancreatic ductal adenocarcinoma","volume":"43","author":"Wang","year":"2022","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.gie.2024.04.012_bib6","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/nm.3973","article-title":"Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell- and patient-derived tumor organoids","volume":"21","author":"Huang","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.gie.2024.04.012_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107588","article-title":"Challenges in establishing pure lung cancer organoids limit their utility for personalized medicine","volume":"31","author":"Dijkstra","year":"2020","journal-title":"Cell Rep"},{"key":"10.1016\/j.gie.2024.04.012_bib8","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1158\/2159-8290.CD-18-0349","article-title":"Organoid profiling identifies common responders to chemotherapy in pancreatic cancer","volume":"8","author":"Tiriac","year":"2018","journal-title":"Cancer Discov"},{"key":"10.1016\/j.gie.2024.04.012_bib9","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1158\/1078-0432.CCR-21-4165","article-title":"Precision medicine in pancreatic cancer: patient-derived organoid pharmacotyping is a predictive biomarker of clinical treatment response","volume":"28","author":"Seppala","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.gie.2024.04.012_bib10","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.gie.2024.04.012_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9070705","article-title":"Multiplex patient-based drug response assay in pancreatic ductal adenocarcinoma","volume":"9","author":"Armstrong","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.gie.2024.04.012_bib12","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.3390\/cancers13112539","article-title":"A prospective feasibility trial to challenge patient-derived pancreatic cancer organoids in predicting treatment response","volume":"13","author":"Beutel","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.gie.2024.04.012_bib13","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/SLA.0000000000005558","article-title":"Pancreatic cancer patient-derived organoids can predict response to neoadjuvant chemotherapy","volume":"276","author":"Demyan","year":"2022","journal-title":"Ann Surg"},{"key":"10.1016\/j.gie.2024.04.012_bib14","doi-asserted-by":"crossref","first-page":"26580","DOI":"10.1073\/pnas.1911273116","article-title":"Pancreatic cancer organoids recapitulate disease and allow personalized drug screening","volume":"116","author":"Driehuis","year":"2019","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.gie.2024.04.012_bib15","first-page":"1","article-title":"CFTR expression analysis for subtyping of human pancreatic cancer organoids","volume":"2019","author":"Hennig","year":"2019","journal-title":"Stem Cells Int"},{"key":"10.1016\/j.gie.2024.04.012_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.xgen.2022.100095","article-title":"Drug screening and genome editing in human pancreatic cancer organoids identifies drug-gene interactions and candidates for off-label therapy","volume":"2","author":"Hirt","year":"2022","journal-title":"Cell Genomics"},{"key":"10.1016\/j.gie.2024.04.012_bib17","doi-asserted-by":"crossref","first-page":"E82","DOI":"10.1055\/a-1713-3404","article-title":"Establishment of organoids using residual samples from saline flushes during endoscopic ultrasound-guided fine-needle aspiration in patients with pancreatic cancer","volume":"10","author":"Ikezawa","year":"2022","journal-title":"Endosc Int Open"},{"key":"10.1016\/j.gie.2024.04.012_bib18","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.21873\/anticanres.15908","article-title":"Standardized methods using EUS-guided fine-needle biopsy and a minimal medium creates three pancreatic cancer organoids","volume":"42","author":"Ishida","year":"2022","journal-title":"Anticancer Res"},{"key":"10.1016\/j.gie.2024.04.012_bib19","doi-asserted-by":"crossref","first-page":"625","DOI":"10.5009\/gnl210166","article-title":"Establishment of patient-derived pancreatic cancer organoids from endoscopic ultrasound-guided fine-needle aspiration biopsies","volume":"16","author":"Lee","year":"2022","journal-title":"Gut Liver"},{"key":"10.1016\/j.gie.2024.04.012_bib20","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1158\/2159-8290.CD-16-1154","article-title":"Personalized in vitro and in vivo cancer models to guide precision medicine","volume":"7","author":"Pauli","year":"2017","journal-title":"Cancer Discov"},{"key":"10.1016\/j.gie.2024.04.012_bib21","doi-asserted-by":"crossref","first-page":"6119","DOI":"10.1016\/j.cell.2021.11.017","article-title":"Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer","volume":"184","author":"Raghavan","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.gie.2024.04.012_bib22","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/SLA.0000000000004200","article-title":"Patient-derived organoid pharmacotyping is a clinically tractable strategy for precision medicine in pancreatic cancer","volume":"272","author":"Seppala","year":"2020","journal-title":"Ann Surg"},{"key":"10.1016\/j.gie.2024.04.012_bib23","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3389\/fonc.2020.00553","article-title":"Metabolic heterogeneity in patient tumor-derived organoids by primary site and drug treatment","volume":"10","author":"Sharick","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.gie.2024.04.012_bib24","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ejca.2021.01.047","article-title":"Development of a system combining comprehensive genotyping and organoid cultures for identifying and testing genotype-oriented personalised medicine for pancreatobiliary cancers","volume":"148","author":"Shiihara","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.gie.2024.04.012_bib25","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s12885-018-4238-4","article-title":"Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models","volume":"18","author":"Tsai","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.gie.2024.04.012_bib26","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1186\/s12885-022-09619-9","article-title":"Establishment of patient-derived organoids and a characterization-based drug discovery platform for treatment of pancreatic cancer","volume":"22","author":"Watanabe","year":"2022","journal-title":"BMC Cancer"}],"container-title":["Gastrointestinal Endoscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016510724002323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016510724002323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T19:44:53Z","timestamp":1777405493000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016510724002323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0016510724002323"],"URL":"https:\/\/doi.org\/10.1016\/j.gie.2024.04.012","relation":{},"ISSN":["0016-5107"],"issn-type":[{"value":"0016-5107","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EUS-guided biopsies versus surgical specimens for establishing patient-derived pancreatic cancer organoids: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Gastrointestinal Endoscopy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gie.2024.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American Society for Gastrointestinal Endoscopy. Published by Elsevier, Inc.","name":"copyright","label":"Copyright"}]}}